Home/Filings/4/0001225208-22-003088
4//SEC Filing

Scanlon Meghan 4

Accession 0001225208-22-003088

CIK 0000885725other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:18 PM ET

Size

8.0 KB

Accession

0001225208-22-003088

Insider Transaction Report

Form 4
Period: 2022-02-21
Scanlon Meghan
SVP,Pres,Urology Pelvic Health
Transactions
  • Exercise/Conversion

    Common Stock

    2022-02-21+77922,515 total
  • Exercise/Conversion

    Deferred Stock Units

    2022-02-21779779 total
    Exp: 2023-02-21Common Stock (779 underlying)
  • Tax Payment

    Common Stock

    2022-02-21$42.55/sh229$9,74422,286 total
Footnotes (2)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeother

Related Parties

1
  • filerCIK 0001801586

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:18 PM ET
Size
8.0 KB